Don't buy LGND now, it is underperforming the market
18 Apr, 20245 min read
LIGAND PHARMACEUTICALS INC ranked among the worst performers on Thursday. It fell by -8.05% to close at 72.52. On a day when the overall market breadth was 44%, it closed higher than 12% of the market. In comparison, the benchmark SP500 index closed today at -0.0022%.